Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Muse cells from human bone marrow help reduce symptoms of atopic dermatitis in mice.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Talquetamab may cause hair loss and skin issues.

Glucocorticoid treatment improved symptoms in a girl with Satoyoshi disease.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

α-MSH and cyclic AMP boost melanin production, while cyclic GMP and melatonin reduce it.

Human hair contains a substance that shows blood group A activity.

Co-trimoxazole may help treat autoimmune diseases.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Clofazimine effectively treated ashy dermatosis in a patient.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Controlled microflora in animals delays immune cell maturation and affects immunity.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Stem cell vesicles reduced eczema symptoms in mice safely.

Early and accurate diagnosis of primary vitreoretinal lymphoma is crucial to prevent serious complications.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.